LU76188A1 - - Google Patents

Info

Publication number
LU76188A1
LU76188A1 LU76188A LU76188A LU76188A1 LU 76188 A1 LU76188 A1 LU 76188A1 LU 76188 A LU76188 A LU 76188A LU 76188 A LU76188 A LU 76188A LU 76188 A1 LU76188 A1 LU 76188A1
Authority
LU
Luxembourg
Application number
LU76188A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU76188A1 publication Critical patent/LU76188A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU76188A 1975-11-13 1976-11-12 LU76188A1 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550959A DE2550959C3 (de) 1975-11-13 1975-11-13 Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
LU76188A1 true LU76188A1 (da) 1977-06-06

Family

ID=5961645

Family Applications (1)

Application Number Title Priority Date Filing Date
LU76188A LU76188A1 (da) 1975-11-13 1976-11-12

Country Status (21)

Country Link
US (1) US4152440A (da)
JP (3) JPS5262278A (da)
AT (1) AT357155B (da)
AU (1) AU504009B2 (da)
BE (1) BE848280A (da)
CA (1) CA1097350A (da)
DE (1) DE2550959C3 (da)
DK (1) DK511376A (da)
ES (1) ES453276A1 (da)
FI (1) FI763215A7 (da)
FR (1) FR2363328A1 (da)
GB (1) GB1545939A (da)
GR (1) GR70648B (da)
HU (1) HU173879B (da)
IE (1) IE44184B1 (da)
IL (1) IL50892A (da)
LU (1) LU76188A1 (da)
NL (1) NL7612610A (da)
NO (1) NO763876L (da)
SE (1) SE7612685L (da)
ZA (1) ZA766715B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071866A (en) * 1989-07-31 1991-12-10 Bristol-Myers Squibb Company Arylpyrazole derivatives as anti-platelet agents
MXPA06014909A (es) 2004-06-18 2007-02-28 Chiron Corp Derivados de n-(1-(1-bencil -4-fenil-1h -imidazol -2-il)-2, 2-dimetilpropil) benzamida y compuestos relacionados como inhibidores de proteina de huso de cinesina (ksp) para el tratamiento del cancer.
GEP20125415B (en) * 2007-01-05 2012-03-12 Novartis Ag Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
WO2008153129A1 (ja) * 2007-06-14 2008-12-18 Teijin Pharma Limited 尿酸値低下剤
MX2011001872A (es) * 2008-08-18 2011-05-23 Univ Yale Moduladores de mif.
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2508511A1 (en) * 2011-04-07 2012-10-10 Laboratoire Biodim Inhibitors of viral replication, their process of preparation and their therapeutical uses

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
BE535047A (da) * 1954-01-21
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
SE7408483L (da) * 1973-07-27 1975-01-28 Ciba Geigy Ag
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
US4152440A (en) 1979-05-01
IL50892A0 (en) 1977-01-31
ZA766715B (en) 1977-10-26
FI763215A7 (da) 1977-05-14
ES453276A1 (es) 1978-02-01
NL7612610A (nl) 1977-05-17
FR2363328A1 (fr) 1978-03-31
JPS5262278A (en) 1977-05-23
AU1952576A (en) 1978-05-18
AU504009B2 (en) 1979-09-27
IL50892A (en) 1981-02-27
CA1097350A (en) 1981-03-10
HU173879B (hu) 1979-09-28
GR70648B (da) 1982-12-03
SE7612685L (sv) 1977-05-14
JPS5547677A (en) 1980-04-04
DK511376A (da) 1977-05-14
ATA844476A (de) 1979-11-15
JPS54163578A (en) 1979-12-26
IE44184B1 (en) 1981-09-09
DE2550959C3 (de) 1980-12-04
GB1545939A (en) 1979-05-16
BE848280A (fr) 1977-05-12
JPS5531155B2 (da) 1980-08-15
NO763876L (da) 1977-05-16
DE2550959A1 (de) 1977-05-26
FR2363328B1 (da) 1979-08-31
IE44184L (en) 1977-05-13
AT357155B (de) 1980-06-25
DE2550959B2 (de) 1980-04-10

Similar Documents

Publication Publication Date Title
FR2321714B1 (da)
FR2363328B1 (da)
JPS5255545U (da)
FR2347633B1 (da)
JPS567714Y2 (da)
JPS5638903B2 (da)
JPS5240004U (da)
JPS5744783Y2 (da)
JPS51121834U (da)
JPS51141440U (da)
JPS51154254U (da)
JPS51114046U (da)
JPS5266036U (da)
CH602531A5 (da)
CH606606A5 (da)
CH590460A5 (da)
CH602135A5 (da)
CH597750A5 (da)
BG21768A1 (da)
CH602120A5 (da)
BG22565A1 (da)
BG21749A1 (da)
CH593593A5 (da)
CH600675A5 (da)
CH604059A5 (da)